Yuyu Pharma, Inc. (KRX:000220)
South Korea
· Delayed Price · Currency is KRW 4,325.00
-5.00 (-0.12%)
At close: Mar 31, 2025, 3:30 PM KST
Yuyu Pharma Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 8,720 | -7,181 | -5,988 | -2,214 | 1,284 | Upgrade
|
| Depreciation & Amortization | 5,666 | 5,607 | 5,027 | 4,503 | 3,899 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1,249 | 98.3 | 248.79 | 3.23 | -282.15 | Upgrade
|
| Asset Writedown & Restructuring Costs | 349.46 | 579.75 | 241.38 | - | 53.65 | Upgrade
|
| Loss (Gain) From Sale of Investments | 370.71 | -657.78 | -182.69 | 139.24 | 110.35 | Upgrade
|
| Loss (Gain) on Equity Investments | -68.58 | 493.69 | -395.07 | -548.18 | -286.22 | Upgrade
|
| Stock-Based Compensation | - | - | - | -42.4 | 85.85 | Upgrade
|
| Provision & Write-off of Bad Debts | -589.56 | 391.86 | -413.97 | 420.18 | 441 | Upgrade
|
| Other Operating Activities | 4,539 | 7,861 | 8,384 | 5,951 | 3,213 | Upgrade
|
| Change in Accounts Receivable | 2,839 | 1,689 | -2,152 | -1,876 | 699.42 | Upgrade
|
| Change in Inventory | 5,913 | -3,424 | -15,134 | -1,367 | -6,840 | Upgrade
|
| Change in Accounts Payable | -1,615 | -5,527 | 7,091 | 3,716 | -1,049 | Upgrade
|
| Change in Other Net Operating Assets | 73.36 | 490.34 | -2,956 | -4,176 | -3,998 | Upgrade
|
| Operating Cash Flow | 24,950 | 420.86 | -6,229 | 4,509 | -2,669 | Upgrade
|
| Operating Cash Flow Growth | 5828.40% | - | - | - | - | Upgrade
|
| Capital Expenditures | -7,112 | -4,514 | -5,283 | -6,073 | -12,047 | Upgrade
|
| Sale of Property, Plant & Equipment | 2,589 | 120 | 4.6 | 19.36 | 2,468 | Upgrade
|
| Cash Acquisitions | - | -890.9 | - | - | - | Upgrade
|
| Divestitures | - | - | - | 1,029 | - | Upgrade
|
| Sale (Purchase) of Intangibles | 172.05 | -591.83 | -285.08 | -677.68 | -2,019 | Upgrade
|
| Investment in Securities | -1,993 | 2,441 | -3,328 | -120.7 | -926.32 | Upgrade
|
| Other Investing Activities | 2,135 | 1,121 | 846.86 | -66.34 | 383.53 | Upgrade
|
| Investing Cash Flow | -4,009 | -2,815 | -8,544 | -5,890 | -12,142 | Upgrade
|
| Long-Term Debt Issued | 3,200 | 37,060 | 2,100 | 35,000 | 16,032 | Upgrade
|
| Total Debt Issued | 3,200 | 37,060 | 2,100 | 35,000 | 16,032 | Upgrade
|
| Long-Term Debt Repaid | -12,230 | -27,349 | -6,984 | -1,610 | -4,979 | Upgrade
|
| Total Debt Repaid | -12,230 | -27,349 | -6,984 | -1,610 | -4,979 | Upgrade
|
| Net Debt Issued (Repaid) | -9,030 | 9,711 | -4,884 | 33,390 | 11,053 | Upgrade
|
| Repurchase of Common Stock | - | - | -1,785 | - | -819.49 | Upgrade
|
| Dividends Paid | - | -2,002 | -2,034 | -1,851 | -1,519 | Upgrade
|
| Other Financing Activities | -829.85 | -549.13 | -380.04 | -225.42 | -203.14 | Upgrade
|
| Financing Cash Flow | -9,860 | 7,160 | -9,083 | 31,313 | 8,511 | Upgrade
|
| Foreign Exchange Rate Adjustments | 146.16 | 0.01 | -568.86 | 8.58 | -223.55 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | 0 | - | - | - | Upgrade
|
| Net Cash Flow | 11,228 | 4,766 | -24,425 | 29,941 | -6,523 | Upgrade
|
| Free Cash Flow | 17,838 | -4,094 | -11,512 | -1,565 | -14,716 | Upgrade
|
| Free Cash Flow Margin | 13.40% | -2.98% | -8.29% | -1.35% | -15.00% | Upgrade
|
| Free Cash Flow Per Share | 957.33 | -220.61 | -694.28 | -98.04 | -1224.65 | Upgrade
|
| Cash Interest Paid | 829.85 | 549.13 | 380.04 | 225.42 | 203.14 | Upgrade
|
| Cash Income Tax Paid | 1,570 | 517.96 | 373.41 | -25.35 | 2,843 | Upgrade
|
| Levered Free Cash Flow | 21,172 | -7,527 | -12,176 | -1,351 | -18,305 | Upgrade
|
| Unlevered Free Cash Flow | 23,184 | -5,931 | -10,563 | 8.33 | -17,206 | Upgrade
|
| Change in Net Working Capital | -16,594 | 5,964 | 9,653 | -1,506 | 10,959 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.